ERBB2 and cancer: The cellular processing of both [177Lu]Lu-PEP49989 and [177Lu]Lu-ABY-027 after binding to cancer cells (Fig. 3) was typical for HER2-binding Affibody molecules, which is characterized by a slow internalization [22, 26].